炔诺孕烯酮（R-2323）和醋酸甲羟孕酮（MPA）的放射免疫测定及其临床适用性。
Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
作者信息
Frick J, Bartsch G, Jakse G
出版信息
Urol Res. 1977;5(2):55-9. doi: 10.1007/BF00256842.
PMID:69351
Abstract
Radioimmunoassays for 2 synthetic progestins (Ethinyl-norgestrienone, R 2323 and medroxyprogesterone acetate, MPA) are demonstrated. 10 patients aged 31 to 72 years were treated with ethinyl-norgestrienone with different schedules and 3 men suffering from benign prostatic hypertrophy were treated with medroxygesterone acetate. Plasma levels of testosterone, LH, FSH were monitored before, during and after treatment.
摘要
展示了两种合成孕激素（炔诺孕烯酮，R 2323和醋酸甲羟孕酮，MPA）的放射免疫测定法。10名年龄在31至72岁的患者接受了不同方案的炔诺孕烯酮治疗，3名患有良性前列腺增生的男性接受了醋酸甲羟孕酮治疗。在治疗前、治疗期间和治疗后监测血浆睾酮、促黄体生成素、促卵泡生成素水平。
Zotero 插件